|[January 30, 2013]
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of BioClinica, Inc. Shareholders
NEW YORK --(Business Wire)--
Kirby McInerney LLP is investigating potential claims against the Board
of Directors of BioClinica, Inc. ("BioClinica" or the "Company")
(NASDAQ: BIOC) related to the proposed acquisition of the Company by JLL
Partners, Inc., a private equity firm. Under the terms of the agreement,
JLL Partners will commence a cash tender offer to purchase all of
BioClinica's common stock for $7.25 per share, valuing the Company at
approximately $123 million.
The investigation concerns whether the BioClinica Board of Directors
violated its fiduciary duties by agreeing to this transaction and
whether the proposed $7.25 per share consideration adequatelyvalues
BioClinica shares. The offer price represents a 19% premium to the
closing price of BioClinica shares the day prior to the announcement. At
least one analyst has a price target for the Company's stock of $9.00
per share, 24% above the offer price.
If you are a BioClinica shareholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email at email@example.com,
or by telephone at (212) 699-1145 or (888) 529-4787, or by filling
out this contact form.
Kirby McInerney LLP is a New York-based law firm concentrating in
securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to www.kmllp.com.
[ Back To Technology News's Homepage ]